Raoul Jean Pierre Bonnal

Raoul Jean Pierre Bonnal

Auto-generated profile, based on publicly available information

Raoul Jean Pierre Bonnal

Database Center for Life Science, Research Organization of Information and Systems, 2-11-16 Yayoi, Bunkyo-ku, Tokyo, 113-0032, Japan

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2016 in Immunity
Verified
Journal Article
Open access
MSMarco De Simone
Marco De Simone
AAAlberto Arrigoni
Alberto Arrigoni
GRGrazisa Rossetti
Grazisa Rossetti
PGPaola Gruarin
Paola Gruarin
VRValeria Ranzani
Valeria Ranzani
MPMassimiliano Pagani
Massimiliano Pagani
Tumor-infiltrating regulatory T lymphocytes (Treg) can suppress effector T cells specific for tumor antigens. Deeper molecular definitions of tumor-infiltrating-lymphocytes could thus offer therapeutic opportunities. Transcriptomes of T helper 1 (Th1), Th17, and Treg cells infiltrating colorectal or non-small-cell lung cancers were compared to transcriptomes of the same subsets from normal tissues and validated at the single-cell level. We found that tumor-infiltrating Treg cells were highly suppressive, upregulated several immune-checkpoints, and expressed on the cell surfaces specific signature molecules such as interleukin-1 receptor 2 (IL1R2), programmed death (PD)-1 Ligand1, PD-1 Ligand2, and CCR8 chemokine, which were not previously described on Treg cells. Remarkably, high expression in whole-tumor samples of Treg cell signature genes, such as LAYN, MAGEH1, or CCR8, correlated with poor prognosis. Our findings provide insights into the molecular identity and functions of human tumor-infiltrating Treg cells and define potential targets for tumor immunotherapy.

26 January 2015 in Nature Immunology
Verified
Journal Article
Open access
PDF file
VRValeria Ranzani
Valeria Ranzani
GRGrazisa Rossetti
Grazisa Rossetti
IPIlaria Panzeri
Ilaria Panzeri
AAAlberto Arrigoni
Alberto Arrigoni
RBRaoul J P Bonnal
Raoul J P Bonnal
MPMassimiliano Pagani
Massimiliano Pagani
Long intergenic noncoding RNAs (lincRNAs) contribute to the regulation of gene expression. Pagani and colleagues identify hundreds of unique lincRNAs expressed in human lymphocytes and demonstrate a role for the lincRNA linc-MAF-4 in the differentiation of CD4+ T cells. Long noncoding RNAs are emerging as important regulators of cellular functions, but little is known of their role in the human immune system. Here we investigated long intergenic noncoding RNAs (lincRNAs) in 13 subsets of T lymphocytes and B lymphocytes by next-generation sequencing–based RNA sequencing (RNA-seq analysis) and de novo transcriptome reconstruction. We identified over 500 previously unknown lincRNAs and described lincRNA signatures. Expression of linc-MAF-4, a chromatin-associated lincRNA specific to the TH1 subset of helper T cells, was inversely correlated with expression of MAF, a TH2-associated transcription factor. Downregulation of linc-MAF-4 skewed T cell differentiation toward the TH2 phenotype. We identified a long-distance interaction between the genomic regions of the gene encoding linc-MAF-4 and MAF, where linc-MAF-4 associated with the chromatin modifiers LSD1 and EZH2; this suggested that linc-MAF-4 regulated MAF transcription through the recruitment of chromatin modifiers. Our results demonstrate a key role for lincRNA in T lymphocyte differentiation.

21 October 2016 in Briefings in Bioinformatics
Verified
Journal Article
Open access
PDF file
TCThe Computational Pan-Genomics Consortium
The Computational Pan-Genomics Consortium
TMTobias Marschall
Tobias Marschall
MMManja Marz
Manja Marz
TAThomas Abeel
Thomas Abeel
LDLouis Dijkstra
Louis Dijkstra
ASAlexander Schönhuth
Alexander Schönhuth
Many disciplines, from human genetics and oncology to plant breeding, microbiology and virology, commonly face the challenge of analyzing rapidly increasing numbers of genomes. In case of Homo sapiens, the number of sequenced genomes will approach hundreds of thousands in the next few years. Simply scaling up established bioinformatics pipelines will not be sufficient for leveraging the full potential of such rich genomic data sets. Instead, novel, qualitatively different computational methods and paradigms are needed. We will witness the rapid extension of computational pan-genomics, a new sub-area of research in computational biology. In this article, we generalize existing definitions and understand a pan-genome as any collection of genomic sequences to be analyzed jointly or to be used as a reference. We examine already available approaches to construct and use pan-genomes, discuss the potential benefits of future technologies and methodologies and review open challenges from the vantage point of the above-mentioned biological disciplines. As a prominent example for a computational paradigm shift, we particularly highlight the transition from the representation of reference genomes as strings to representations as graphs. We outline how this and other challenges from different application domains translate into common computational problems, point out relevant bioinformatics techniques and identify open problems in computer science. With this review, we aim to increase awareness that a joint approach to computational pan-genomics can help address many of the problems currently faced in various domains.

1 July 2008 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
MIMichele Iacono
Michele Iacono
LVLaura Villa
Laura Villa
DFDaniela Fortini
Daniela Fortini
RBRoberta Bordoni
Roberta Bordoni
FIFrancesco Imperi
Francesco Imperi
ACAlessandra Carattoli
Alessandra Carattoli
The whole-genome sequence of an epidemic, multidrug-resistant Acinetobacter baumannii strain (strain ACICU) belonging to the European clone II group and carrying the plasmid-mediated bla OXA - 58 carbapenem resistance gene was determined. The A. baumannii ACICU genome was compared with the genomes of A. baumannii ATCC 17978 and Acinetobacter baylyi ADP1, with the aim of identifying novel genes related to virulence and drug resistance. A. baumannii ACICU has a single chromosome of 3,904,116 bp (which is predicted to contain 3,758 genes) and two plasmids, pACICU1 and pACICU2, of 28,279 and 64,366 bp, respectively. Genome comparison showed 86.4% synteny with A. baumannii ATCC 17978 and 14.8% synteny with A. baylyi ADP1. A conspicuous number of transporters belonging to different superfamilies was predicted for A. baumannii ACICU. The relative number of transporters was much higher in ACICU than in ATCC 17978 and ADP1 (76.2, 57.2, and 62.5 transporters per Mb of genome, respectively). An antibiotic resistance island, AbaR2, was identified in ACICU and had plausibly evolved by reductive evolution from the AbaR1 island previously described in multiresistant strain A. baumannii AYE. Moreover, 36 putative alien islands (pAs) were detected in the ACICU genome; 24 of these had previously been described in the ATCC 17978 genome, 4 are proposed here for the first time and are present in both ATCC 17978 and ACICU, and 8 are unique to the ACICU genome. Fifteen of the pAs in the ACICU genome encode genes related to drug resistance, including membrane transporters and ex novo acquired resistance genes. These findings provide novel insight into the genetic basis of A. baumannii resistance.

26 June 2011 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
Riccardo Lorenzo RossiRiccardo Lorenzo Rossi
Riccardo Lorenzo Rossi
GRGrazisa Rossetti
Grazisa Rossetti
LWLynn Wenandy
Lynn Wenandy
SCSerena Curti
Serena Curti
ARAnna Ripamonti
Anna Ripamonti
MPMassimiliano Pagani
Massimiliano Pagani

1 January 2009 in BMC Genomics
Verified
Journal Article
Open access
PDF file
AGAlessandro Guffanti
Alessandro Guffanti
MIMichele Iacono
Michele Iacono
PPParide Pelucchi
Paride Pelucchi
NKNamshin Kim
Namshin Kim
GSGiulia Soldà
Giulia Soldà
GBGianluca De Bellis
Gianluca De Bellis
The cancer transcriptome is difficult to explore due to the heterogeneity of quantitative and qualitative changes in gene expression linked to the disease status. An increasing number of "unconventional" transcripts, such as novel isoforms, non-coding RNAs, somatic gene fusions and deletions have been associated with the tumoral state. Massively parallel sequencing techniques provide a framework for exploring the transcriptional complexity inherent to cancer with a limited laboratory and financial effort. We developed a deep sequencing and bioinformatics analysis protocol to investigate the molecular composition of a breast cancer poly(A)+ transcriptome. This method utilizes a cDNA library normalization step to diminish the representation of highly expressed transcripts and biology-oriented bioinformatic analyses to facilitate detection of rare and novel transcripts.